Massachusetts-based brain implant company Axoft raised a $55M Series A and says it tested its device in a Shanghai patient, with plans for more trials in China
With this $55M Series A Axoft will go further and faster than ever before. We have already expanded our clinical footprint with cases across US, China and South America. …